Table 1.
Medical and pharmacy claims’ costs.
| Control group | OMRON test group | % Difference in PMPM | p-value | |||
|---|---|---|---|---|---|---|
| Total | PMPM | Total | PMPM | |||
| All medical claims | $918,429 | $819 | $586,235 | $522 | −36% | 0.1115 |
| Hypertension-related | $13,947 | $12 | $18,130 | $16 | 30% | <0.0001 |
| Cardiovascular-related | $167,551 | $149 | $89,088 | $79 | −47% | 0.4702 |
| Emergency room | $248,835 | $222 | $38,226 | $34 | −85% | 0.2747 |
| CV ER | $72,176 | $64 | $28,434 | $25 | −61% | 0.6361 |
| All pharmacy claims | $276,893 | $261 | $175,168 | $165 | −37% | 0.0108 |
| Hypertension drugs | $11,735 | $11 | $8,416 | $8 | −28% | 0.0558 |
Claims incurred by OMRON test group members and their matched controls in the six-month post-enrollment period are summarized in the table above. Total columns show the sum over the entire group and time period; PMPM columns are per member per month. P-values were obtained from two-sided two-sample Wilcoxon rank-sum tests and were considered significant at the α = 0.05 level.